Companies aren’t waiting for New York’s health departments to finalize key details of its medical-marijuana program to start selling cannabis-based products.
Axim Biotech, which has offices in New York and the Netherlands, wants to sell a line of anti-inflammatory, cannabis-based toothpaste and mouthwash that the company claims could be on drugstore shelves by this fall, along with a line of skin-care products.
Its dental products won’t require any FDA regulation because they are not considered medical, said Chief Executive Dr. George Anastassov. Sold under the brand name Oraximax, they will be “priced competitively,” said the company’s chief medical officer, Dr. Philip Van Damme.
Axim is also developing cannabinoid-based pharmaceuticals in its Netherlands location. It currently is conducting a clinical trial for a cannabinoid-based painkiller that is expected to come on the market in two years, Dr. Anastassov said. “There has been nothing new in the pain-management market for the last 30 years,” he said. “Meanwhile, the population is aging, and people have a much more active lifestyle than they used to.” [Read more at Crain’s New York Business]
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
About 30,000 cannabis enthusiasts are expected to trek through the Sonoma County Fairgrounds next weekend for the revamped Emerald Cup Harvest Ball, a celebration all about the plant that has been a social, regulatory and business fixture for decades in Northern California. Those pot lovers will learn about new, innovative weed strains, while some of…
The Vermont Cannabis Control Board has decided not to recommend specific warning labels on the health effects of cannabis products, and James Pepper, the board chair, explained to VTDigger how the board made the decision. The Vermont Medical Society urged the board and the Legislature this week to require warnings that cannabis and its main…
ONE year on from the formal recognition of the potential for cannabis as a medicine almost 200 global advocacy and civil society groups are backing for calls for greater transparency over emerging new cannabis guidelines. On December 2, last year the United Nations Commission on Narcotic Drugs (CND) rescheduled cannabis recognising its medical properties for…
SAN FRANCISCO (BCN) — San Francisco supervisors on Tuesday unanimously approved an ordinance to suspend the city’s Cannabis Business Tax through the end of next year, in an attempt to curb illegal marijuana sales. According to Supervisor Rafael Mandelman, the legislation’s author, suspending the city business tax through Dec. 31, 2022, would help support legal…